In modern medicine, it is crucial to have diagnostic tools capable of capturing detailed and specific information about every type of biological sample.

The most innovative and advanced tools allow for the collection, preservation, and rapid analysis of complex substances, essential for studying diseases such as aging, cancer, rare, neurodegenerative, and metabolic diseases.

Advanced analyses are fundamental for clinical research and patient monitoring, as they enable understanding of how metabolites change in response to genetic mutations or drug actions. Identifying even the smallest variations between different samples is crucial for improving diagnostic accuracy and treatment effectiveness.

However, the adoption of these advanced technologies is often limited by high costs and the need for specialized personnel. Overcoming these barriers is essential to make precise and personalized diagnoses more accessible and widespread.

Crescendo Care: advanced bioanalytics beyond standard biological samples

Crescendo Care is a startup that stands out in the field of advanced bioanalytics; it develops new technologies for processing and analyzing biological samples and offers advanced consulting and targeted analysis services using techniques such as UPLC-MS/MS, which combines high-precision liquid chromatography with mass spectrometry.

The company provides research centers, biobanks, or companies in the sector with innovative devices for the collection and preservation of samples and the ability to perform analyses that can accurately assess biochemical conditions at the time of collection, thus ensuring precise results even for metabolites sensitive to environmental variations, such as thiols.

This approach makes it possible to identify molecules that are not detectable with traditional methods, thereby identifying new therapeutic targets and defining personalized treatments. Moreover, Crescendo Care has laboratories capable of analyzing a wide variety of biological samples, from standard ones like plasma and urine to cellular matrices and cellular organelles (such as mitochondria), and carrying out membrane and tissue studies.

Crescendo Care not only meets the growing needs in the field of medical diagnostics but also sets new standards for more precise and personalized analysis, improving the understanding of diseases and their treatment and promoting a future of tailored care for every patient.

State of the art

Starting from the solid expertise of the team in the collection and processing of biological samples and targeted analysis using UPLC-MS/MS, Crescendo Care aims to expand its analytical capabilities and remain at the forefront of emerging technologies in the field.

Crescendo Care Joins the Bio4Dreams Ecosystem

With the start of a personalized incubation path, Crescendo Care has joined the Bio4Dreams ecosystem, opening up the possibility of numerous potential synergies with other entities already present in the network.

“At Crescendo Care, we believe in the transformative power of precise and personalized diagnostics. Our mission is to support research and clinical practice by offering a cutting-edge team and advanced technologies in the field of bioanalysis. Our dedication to developing and validating innovative diagnostic methods and providing high-quality consulting makes Crescendo Care a formidable ally for those operating on the frontier of personalized medicine.”

Simona Roggero, Co-founder, Crescendo Care

📗 Learn more about Crescendo Care and other entities in our portfolio.